|
Volumn 16, Issue 4, 2010, Pages 500-502
|
Suppressive effect of glucocorticoids on TNF-α production is associated with their clinical effect in multiple sclerosis
|
Author keywords
Corticosteroids; Cytokines; Multiple sclerosis; Treatment response
|
Indexed keywords
DEXAMETHASONE;
GLUCOCORTICOID;
METHYLPREDNISOLONE;
TUMOR NECROSIS FACTOR ALPHA;
AUTACOID;
BIOLOGICAL MARKER;
ADULT;
ARTICLE;
CLINICAL ARTICLE;
CYTOKINE PRODUCTION;
DRUG EFFECT;
DRUG EFFICACY;
DRUG MEGADOSE;
FEMALE;
HUMAN;
IN VITRO STUDY;
MALE;
MORNING DOSAGE;
MULTIPLE SCLEROSIS;
PROSPECTIVE STUDY;
BLOOD;
CLINICAL TRIAL;
DISABILITY;
DOSE RESPONSE;
DOWN REGULATION;
DRUG RESISTANCE;
IMMUNOLOGY;
MIDDLE AGED;
MONONUCLEAR CELL;
TREATMENT OUTCOME;
ADULT;
BIOLOGICAL MARKERS;
DEXAMETHASONE;
DISABILITY EVALUATION;
DOSE-RESPONSE RELATIONSHIP, DRUG;
DOWN-REGULATION;
DRUG RESISTANCE;
FEMALE;
GLUCOCORTICOIDS;
HUMANS;
INFLAMMATION MEDIATORS;
LEUKOCYTES, MONONUCLEAR;
MALE;
METHYLPREDNISOLONE;
MIDDLE AGED;
MULTIPLE SCLEROSIS, CHRONIC PROGRESSIVE;
MULTIPLE SCLEROSIS, RELAPSING-REMITTING;
PROSPECTIVE STUDIES;
TREATMENT OUTCOME;
TUMOR NECROSIS FACTOR-ALPHA;
|
EID: 77954662767
PISSN: 13524585
EISSN: None
Source Type: Journal
DOI: 10.1177/1352458509359721 Document Type: Article |
Times cited : (15)
|
References (2)
|